Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Rat/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene B protein (44-94 aa) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
SLC22A18ASUniprot ID=BWR1B_HUMAN" |
Immunogen Region: |
44-94 aa |
Specificity: |
This antibody detects endogenous levels of BWR1B at Human |
Immunogen: |
Synthesized peptide derived from the human BWR1B at the amino acid range 44-94 |
Protein Name | Beckwith-Wiedemann Syndrome Chromosomal Region 1 Candidate Gene B ProteinOrganic Cation Transporter-Like Protein 2 Antisense ProteinSolute Carrier Family 22 Member 1-Like Antisense ProteinSolute Carrier Family 22 Member 18 Antisense ProteinP27-Beckwith-Wiedemann Region 1 BP27-Bwr1b |
Alternative Antibody Names | Anti-Beckwith-Wiedemann Syndrome Chromosomal Region 1 Candidate Gene B Protein antibodyAnti-Organic Cation Transporter-Like Protein 2 Antisense Protein antibodyAnti-Solute Carrier Family 22 Member 1-Like Antisense Protein antibodyAnti-Solute Carrier Family 22 Member 18 Antisense Protein antibodyAnti-P27-Beckwith-Wiedemann Region 1 B antibodyAnti-P27-Bwr1b antibodyAnti-SLC22A18AS antibodyAnti-BWR1B antibodyAnti-BWSCR1B antibodyAnti-ORCTL2S antibodyAnti-SLC22A1LS antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance